Phase I Study of TORL-2-307-ADC in Patients with Advanced Solid Tumors, including Pancreatic Cancer
Summary
The purpose of this phase I trial is to evaluate the safety and tolerability of TORL-2-307-ADC in patients with advanced solid tumors, including pancreatic cancer.
General Information
NCT#: NCT05156866
Study ID: TORL2307ADC-001
Trial Phase: Phase I
Trial Sponsor: TORL Biotherapeutics, LLC
Therapies Used in This Trial: TORL-2-307-ADC